Join us at the American Conference Institute's Paragraph IV Disputes: Expert Insights on Hatch-Waxman Litigation Strategies for Brand Names and Generics.  Attorney Kristin Cooklin will represent Kilpatrick Townsend on a panel titled Damages and Injunctions: Exploring the Consequences and Conundrums of Launching at Risk, which will explore and discuss damages and injunctions, particularly with respect to launching a generic pharmaceutical product "at-risk." The procedure of injunctions and appeals will be discussed, as well as an analysis and discussion of recent and topical cases.

For information on this event, click here.